13D/13G Filings - RA Capital Management, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...3, 4, 5, 6, 7, ...24, 25, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-05-30
6:57 pm
Purchase
2024-05-20 13G Structure Therapeutics Inc.
GPCR
RA Capital Management, L.P. 7,225,311
5.200%
7,225,311increase
(New Position)
Filing
History
2024-05-17
4:18 pm
Purchase
2024-05-15 13D Climb Bio, Inc.
CLYM
RA Capital Management, L.P. 13,190,292
45.300%
556increase
(+0.00%)
Filing
History
2024-05-14
9:10 pm
Sale
2024-05-10 13D iTeos Therapeutics, Inc.
ITOS
RA Capital Management, L.P. 3,659,046
9.990%
-758,213decrease
(-17.16%)
Filing
History
2024-05-10
5:52 pm
Purchase
2024-04-30 13G MEDICENNA THERAPEUTICS CORP
MDNAF
RA Capital Management, L.P. 7,714,760
9.990%
7,714,760increase
(New Position)
Filing
History
2024-05-09
8:48 pm
Purchase
2024-05-07 13D Black Diamond Therapeutics, Inc.
BDTX
RA Capital Management, L.P. 2,788,028
4.950%
198,124increase
(+7.65%)
Filing
History
2024-05-07
4:52 pm
Purchase
2024-05-03 13D Werewolf Therapeutics, Inc.
HOWL
RA Capital Management, L.P. 6,192,881
14.200%
13,846increase
(+0.22%)
Filing
History
2024-05-06
5:57 pm
Purchase
2024-04-26 13G Avidity Biosciences, Inc.
RNA
RA Capital Management, L.P. 4,895,959
5.100%
2,441,426increase
(+99.47%)
Filing
History
2024-05-02
5:58 pm
Purchase
2024-04-22 13G Zura Bio Limited
ZURA
RA Capital Management, L.P. 3,217,503
5.100%
3,217,503increase
(New Position)
Filing
History
2024-04-30
4:16 pm
Purchase
2024-04-26 13D Aerovate Therapeutics, Inc.
AVTE
RA Capital Management, L.P. 8,313,982
28.900%
20,834increase
(+0.25%)
Filing
History
2024-04-25
8:43 pm
Purchase
2024-04-10 13G Protara Therapeutics, Inc.
TARA
RA Capital Management, L.P. 2,073,075
9.990%
2,073,075increase
(New Position)
Filing
History
2024-04-15
4:45 pm
Purchase
2024-04-04 13G Surrozen, Inc.
SRZN
RA Capital Management, L.P. 323,662
9.990%
323,662increase
(New Position)
Filing
History
2024-04-12
6:52 pm
Purchase
2024-04-10 13D Climb Bio, Inc.
CLYM
RA Capital Management, L.P. 13,189,736
47.500%
10,555increase
(+0.08%)
Filing
History
2024-04-12
4:24 pm
Purchase
2024-04-02 13G Boundless Bio, Inc.
BOLD
RA Capital Management, L.P. 2,180,631
9.800%
2,180,631increase
(New Position)
Filing
History
2024-04-11
7:55 pm
Purchase
2024-04-01 13G CervoMed Inc.
CRVO
RA Capital Management, L.P. 825,373
9.990%
825,373increase
(New Position)
Filing
History
2024-04-11
4:16 pm
Purchase
2024-04-11 13D Acrivon Therapeutics, Inc. Common Stock
ACRV
RA Capital Management, L.P. 8,359,102
27.100%
3,541,743increase
(+73.52%)
Filing
History
2024-04-04
7:04 pm
Purchase
2024-03-25 13G Dyne Therapeutics, Inc.
DYN
RA Capital Management, L.P. 5,213,661
6.400%
5,213,661increase
(New Position)
Filing
History
2024-04-01
7:33 pm
Purchase
2024-03-20 13G Sera Prognostics, Inc.
SERA
RA Capital Management, L.P. 2,047,221
6.500%
2,047,221increase
(New Position)
Filing
History
2024-03-29
5:41 pm
Purchase
2024-03-27 13D Nkarta, Inc.
NKTX
RA Capital Management, L.P. 13,848,371
18.900%
6,016,031increase
(+76.81%)
Filing
History
2024-03-29
4:14 pm
Purchase
2024-03-27 13D ARS Pharmaceuticals, Inc.
SPRY
RA Capital Management, L.P. 10,860,977
11.300%
1,401,299increase
(+14.81%)
Filing
History
2024-03-29
12:54 pm
Purchase
2024-03-19 13G Alto Neuroscience, Inc.
ANRO
RA Capital Management, L.P. 1,385,491
5.200%
1,385,491increase
(New Position)
Filing
History
Goto Prev, 0, 1, ...3, 4, 5, 6, 7, ...24, 25, Next